Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.80
Delayed Data
As of Mar 23
 0.00 / 0.00%
Today’s Change
5.20
Today|||52-Week Range
9.32
+34.35%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close8.80
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)40,335
Market cap$201.1M
Dividend yield--
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)-143.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+19.07%
Revenue growth (last year)-5.35%
P/E ratio--
Price/Sales3.12
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.13+2.80%
CYADCelyad SA+0.33+1.53%
VBIVVBI Vaccines Inc-0.01-0.19%
SELBSelecta Biosciences ...+1.15+10.56%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 18, 2017
EPS forecast (this quarter)$0.06
Annual revenue (last year)$47.7M
Annual profit (last year)-$2.9M
Net profit margin-6.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts


Search for Jobs